The company is also raising its full-year guidance to $14.9 billion in adjusted EBITDA, an 8.8% increase from its last ...

AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments ...

Although some products like Imfinzi/Imjudo and Soliris underperformed, overall, the company’s performance was bolstered by significant gains in other segments, such as Symbicort and Ultomiris.

The company’s comprehensive portfolio includes leading lung cancer medicines and the next wave of innovations, including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi (durvalumab) and Imjudo ...

Meanwhile, also gunning for a piece of the market is AstraZeneca, which in June won FDA approval for its PD-L1 inhibitor Imfinzi (durvalumab) alongside chemo as front-line therapy for endometrial ...

Imfinzi is also approved on early data, pending the outcome of a larger study that also aims to provide solid OS data. Bavencio has been approved for maintenance treatment of patients with ...

A trader works at the New York Stock Exchange (NYSE), after Republican presidential nominee Donald Trump won the election, in New York City, U.S., November 6, 2024. REUTERS/Andrew Kelly/File Photo ...

Voting is underway in Kerala's Wayanad Lok Sabha constituency for the by-election. Congress leader Priyanka Gandhi Vadra is making her electoral debut against 15 other candidates. The bypoll was ...

Kilkis, a lesser-known gem in northern Greece, offers a mix of natural beauty, history, and cultural experiences. A new study has revealed that Kilkis is the most affordable destination in Greece and ...

The collision caused the rider to flip over the bike’s handle bars before landing on top of the car.

‘I knew I should wait for the police (but) I knew that there is a chance that there’s a woman in there that needs help.’ ...